ConductScience.org, home

Paper · 19479727

Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components.

Marchiò C and 15 others. J Pathol, 2009. Cited by 60 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components. Papers, record 19479727. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19479727

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components.
PubMed
Journal
J Pathol
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
60
iCite
Relative citation ratio, by iCite
1.27
iCite
Revised in PubMed
2025-05-29
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marchiò CCaterina
2Iravani MMarjan
3Natrajan RRachael
4Lambros MBMaryou B K
5Geyer FCFelipe C
6Savage KKay
7Parry SSuzanne
8Tamber NNarinder
9Fenwick KKerry
10Mackay AAlan

1 to 10 of 16Source PubMed

See all 16 authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Carcinoma, Ductal, BreastMajor topic
Carcinoma, PapillaryMajor topic
Neoplasms, Complex and MixedMajor topic
Biomarkers, Tumor
Chromosome Aberrations
Comparative Genomic Hybridization
Female
Humans
Immunophenotyping
Neoplasm Proteins
Oligonucleotide Array Sequence Analysis

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
BREAST CANCER NOW RESEARCH CENTREBreast Cancer NowUnited KingdomPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.

PMIDTitleJournalYearIn PapersSource
35,013,309Genomic alterations and evolution of cell clusters in metastatic invasive micropapillary carcinoma of the breast.Nat Commun2022https://conductscience.org/library/papers/35013309PubMed
34,734,332Papillary lesions of the breast.Virchows Arch2022https://conductscience.org/library/papers/34734332PubMed
33,842,633Differences in the clinicopathological characteristics of pure and mixed invasive micropapillary breast carcinomas from eastern China.Ann Transl Med2021https://conductscience.org/library/papers/33842633PubMed
33,425,023Evaluation of efficacy of chemotherapy for mucinous carcinoma: a surveillance, epidemiology, and end results cohort study.Ther Adv Med Oncol2020https://conductscience.org/library/papers/33425023PubMed
33,212,478HER2 Immunohistochemistry in Invasive Micropapillary Breast Carcinoma: Complete Assessment of an Incomplete Pattern.Arch Pathol Lab Med2021https://conductscience.org/library/papers/33212478PubMed
33,203,200[Pathological and Molecular Features of Lung Micropapillary Adenocarcinoma].Zhongguo Fei Ai Za Zhi2020https://conductscience.org/library/papers/33203200PubMed
32,210,163Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments.Med Sci (Basel)2020https://conductscience.org/library/papers/32210163PubMed
31,839,814A Competing Nomogram to Predict Survival Outcomes in Invasive Micropapillary Breast Cancer.J Cancer2019https://conductscience.org/library/papers/31839814PubMed
31,118,443Exploring Collagen Parameters in Pure Special Types of Invasive Breast Cancer.Sci Rep2019https://conductscience.org/library/papers/31118443PubMed
30,670,771Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis.Sci Rep2019https://conductscience.org/library/papers/30670771PubMed

1 to 10 of 33

See all 33 cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19479727

GET https://conductscience.org/api/papers/v1/19479727/cited_by?page=2